Neuroparasitic infections: Cestodes, trematodes, and protozoans

Seminars in Neurology

Volumn 25, Issue 3, 2005, Pages 262-277

  Walker, M D ^b   Zunt, Joseph R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cestodes; Nervous system; Parasite; Protozoan; Trematode

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; ANTICONVULSIVE AGENT; ARTEMETHER; BENZNIDAZOLE; BITHIONOL; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; DEXAMETHASONE; EFLORNITHINE; KETOCONAZOLE; MELARSOPROL; MICONAZOLE; OXAMNIQUINE; PENTAMIDINE ISETHIONATE; PRAZIQUANTEL; RIFAMPICIN; STEROID; SULFAFURAZOLE; TRICLABENDAZOLE;

ABDOMINAL PAIN; ACANTHAMOEBA; ACANTHAMOEBA HISTOLYTICA; ALOPECIA; BALAMUTHIA MANDRILLARIS; BRAIN INFECTION; CEREBROSPINAL FLUID ANALYSIS; CESTODIASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIPHYLLOBOTHRIASIS; ECHINOCOCCUS; ERYTHROCYTE SEDIMENTATION RATE; HEARING LOSS; HEART ARRHYTHMIA; HUMAN; HYPOKALEMIA; HYPOTENSION; INCIDENCE; JAUNDICE; LEUKOPENIA; LIVER FAILURE; MENINGOENCEPHALITIS; NAEGLERIA FOWLERI; NAUSEA; NEUROIMAGING; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PARAGONIMUS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; SACCHAROMYCES; SCHISTOSOMA; SEIZURE; SIDE EFFECT; SKIN ALLERGY; SPIROMETRA; SYMPTOM; TREMATODIASIS; TRYPANOSOMA; VOMITING;

ANIMALS; CESTODE INFECTIONS; HUMANS; NERVOUS SYSTEM DISEASES; PROTOZOAN INFECTIONS; TREMATODE INFECTIONS;

EID: 26444544606     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-917663     Document Type: Review

References (137)

1. Algros MP, Majo F, Bresson-Hadni S, et al. Intracerebral alveolar echinococcosis. Infection 2003;31:63-65
2. Al Zain TJ, Al-Witiy SH, Khalili HM, et al. Multiple intracranial hydatidosis. Acta Neurochir (Wien) 2002;144: 1179-1185
3. Lewall DB. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol 1998;53:863-874
4. Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003;9:343-349
5. Bouree P. Hydatidosis: dynamics of transmission. World J Surg 2001;25:4-9
6. Garret M, Herbsman H, Fierst S. Cytologic diagnosis of echinococcosis. Acta Cytol 1977;21:553-554
7. Farmer PM, Chatterley S, Spier N. Echinococcal cyst of the liver: diagnosis and surgical management. Ann Clin Lab Sci 1990;20:385-391
8. Gottstein B, Reichen J. Hydatid lung disease (echinococcosis/hydatidosis) . Clin Chest Med 2002;23:397-408
9. Ramadan NI, Abel Aaty HE, Mahmoud MS, El Nori A. An enzyme-linked immunoelectrotransfer blot assay for diagnosis of human cystic echinococcosis. J Egypt Soc Parasitol 1999;29:849-857
10. Jiang L, Wen H, Ito A. Immunodiagnostic differentiation of alveolar and cystic echinococcosis using ELISA test with 18-kDa antigen extracted from Echinococcus protoscoleces. Trans R Soc Trop Med Hyg 2001;95:285-288
11. Kanwar JR, Kaushik SP, Sawhney IM, et al. Specific antibodies in serum of patients with hydatidosis recognised by immunoblotting. J Med Microbiol 1992;36:46-51
12. Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992;5:248-261
13. Tuzun M, Altinors N, Arda IS, Hekimoglu B. Cerebral hydatid disease CT and MR findings. Clin Imaging 2002; 26:353-357
14. CDC. DPDx Laboratory diagnosis of parasites of public health concern. Vol. 2003: Centers for Disease Control and Prevention; 2003
15. el-Mufti M, Kamag A, Ibrahim H, et al. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Ann Trop Med Parasitol 1993;87:241-246
16. Lee KJ, Bae YT, Kim DH, et al. A seroepidemiologic survey for human sparganosis in Gangweon-do. Korean J Parasitol 2002;40:177-180
17. Landero A, Hernandez F, Abasolo MA, et al. Cerebral sparganosis caused by Spirometra mansonoides. Case report. J Neurosurg 1991;75:472-474
18. Noya O, Alarcon de Noya B, Arrechedera H, et al. Sparganum proliferum: an overview of its structure and ultrastructure. Int J Parasitol 1992;22:631-640
19. Fontan R, Beauchamp F, Beaver PC. [New helminthiases in Laos. II. Plathelminths]. Bull Soc Pathol Exot Filiales 1975;68:566-573
20. Li X. Food-borne parasitic zoonoses in the People's Republic of China. Southeast Asian J Trop Med Public Health 1991; 22(suppl):31-35
21. Hughes AJ, Biggs BA. Parasitic worms of the central nervous system: an Australian perspective. Intern Med J 2002;32: 541-553
22. Schmid H, Watschinger H. Sparganosis in the Masailand. Acta Trop 1972;29:218-230
23. Moulinier R, Martinez E, Torres J, et al. Human proliferative sparganosis in Venezuela: report of a case. Am J Trop Med Hyg 1982;31:358-363
24. Cummings TJ, Madden JF, Gray L, et al. Parasitic lesion of the insula suggesting cerebral sparganosis: case report. Neuroradiology 2000;42:206-208
25. Gray ML, Rogers F, Little S, et al. Sparganosis in feral hogs (Sus scrofa) from Florida. J Am Vet Med Assoc 1999;215: 204-208
26. Park HY, Lee SU, Kim SH, et al. Epidemiological significance of sero-positive inhabitants against sparganum in Kangwon-do, Korea. Yonsei Med J 2001;42:371-374
27. Mastura AB, Ambu S, Hasnah O, Rosli R. Spargana infection of frogs in Malaysia. Southeast Asian J Trop Med Public Health 1996;27:51-52
28. Tsou MH, Huang TW. Pathology of subcutaneous sparganosis: report of two cases. J Formos Med Assoc 1993;92:649-653
29. Kron MA, Guderian R, Guevara A, Hidalgo A. Abdominal sparganosis in Ecuador: a case report. Am J Trop Med Hyg 1991;44:146-150
30. Rywlin AM, Beck JW, Snyder GB. Sparganosis in Florida. Arch Dermatol 1968;97:425-427
31. Norman SH, Kreutner A Jr. Sparganosis: clinical and pathologic observations in ten cases. South Med J 1980;73: 297-300
32. Taylor RL. Sparganosis in the United States. Report of a case. Am J Clin Pathol 1976;66:560-564
33. Mueller JF. Potential longevity of life history stages of Spirometra spp. J Parasitol 1974;60:376-377
34. Chang JH, Lin OS, Yeh KT. Subcutaneous sparganosis - a case report and a review of human sparganosis in Taiwan. Kaohsiung J Med Sci 1999;15:567-571
35. Pampiglione S, Fioravanti ML, Rivasi F. Human sparganosis in Italy. Case report and review of the European cases. APMIS 2003;111:349-354
36. Chang KH, Chi JG, Cho SY, et al. Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology 1992;34:1-8
37. Botterel F, Bouree P. Ocular sparganosis: a case report. J Travel Med 2003;10:245-246
38. Campbell EW, Seals C. Striking eosinophilia in sparganosis. Postgrad Med 1977;62:138-140
39. Fan KJ, Pezeshkpour GH. Cerebral sparganosis. Neurology 1986;36:1249-1251
40. Sarma DP, Weilbaecher TG. Human sparganosis. J Am Acad Dermatol 1986;15:1145-1148
41. Nishiyama T, Ide T, Himes SR Jr, et al. Immunodiagnosis of human sparganosis mansoni by micro-chemiluminescence enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 1994;88:663-665
42. Moon WK, Chang KH, Cho SY, et al. Cerebral sparganosis: MR imaging versus CT features. Radiology 1993;188:751-757
43. Jeong SC, Bae JC, Hwang SH, et al. Cerebral sparganosis with intracerebral hemorrhage: a case report. Neurology 1998;50:503-506
44. Han SR, Park JK, Kim YI, Son BC. Posterior cerebral artery infarction caused by cerebral sparganosis-induced vasculitis. Eur Neurol 2001;46:105-107
45. Ishii H, Mukae H, Inoue Y, et al. A rare case of eosinophilic pleuritis due to sparganosis. Intern Med 2001;40:783-785
46. Kim DG, Paek SH, Chang KH, et al. Cerebral sparganosis: clinical manifestations, treatment, and outcome. J Neurosurg 1996;85:1066-1071
47. Torres JR, Noya OO, Noya BA, et al. Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg 1981;75:846-847
48. Blair D, Xu ZB, Agatsuma T. Paragonimiasis and the genus Paragonimus. Adv Parasitol 1999;42:113-222
49. Kim DC. Paragonimus westermani: life cycle, intermediate hosts, transmission to man and geographical distribution in Korea. Arzneimittelforschung 1984;34:1180-1183
50. Miyazaki I, Hirose H. Immature lung flukes first found in the muscle of the wild boar in Japan. J Parasitol 1976;62: 836-837
51. Choi WY. Paragonimus westermani: pathogenesis and clinical features of infection. Arzneimittelforschung 1984; 34:1184-1185
52. Oh SJ. Cerebral and spinal paragonimiasis. A histopathological study. J Neurol Sci 1969;9:205-236
53. Kusner DJ, King CH. Cerebral paragonimiasis. Semin Neurol 1993;13:201-208
54. Ashitani J, Kumamoto K, Matsukura S. Paragonimiasis westermani with multifocal lesions in lungs and skin. Intern Med 2000;39:433-436
55. Kagawa FT. Pulmonary paragonimiasis. Semin Respir Infect 1997;12:149-158
56. Kang SY, Kim TK, Kim TY, et al. A case of chronic cerebral paragonimiasis westermani. Korean J Parasitol 2000;38:167-171
57. Kan H, Ogata T, Taniyama A, et al. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani. Pediatrics 1995;96:351-354
58. Kim TY, Joo IJ, Kang SY, et al. Recombinant Paragonimus westermani yolk ferritin is a useful serodiagnostic antigen. J Infect Dis 2002;185:1373-1375
59. Oh SJ. Paragonimus meningitis. J Neurol Sci 1968;6:419-433
60. Yoshida M, Moritaka K, Kuga S, Anegawa S. CT findings of cerebral paragonimiasis in the chronic state. J Comput Assist Tomogr 1982;6:195-196
61. Udaka F, Okuda B, Okada M, et al. CT findings of cerebral paragonimiasis in the chronic state. Neuroradiology 1988; 30:31-34
62. El-Garem AA. Schistosomiasis. Digestion 1998;59:589-605
63. Pittella JE. Neuroschistosomiasis. Brain Pathol 1997;7:649-662
64. Zheng J, Gu XG, Xu YL, et al. Relationship between the transmission of schistosomiasis japonica and the construction of the Three Gorge Reservoir. Acta Trop 2002;82:147-156
65. Babiker SM, Blankespoor HD, Wassila M, et al. Transmission of Schistosoma haematobium in North Gezira, Sudan. J Trop Med Hyg 1985;88:65-73
66. Liu LX. Spinal and cerebral schistosomiasis. Semin Neurol 1993;13:189-200
67. Pollner JH, Schwartz A, Kobrine A, Parenti DM. Cerebral Schistosomiasis caused by Schistosoma haematobium: case report. Clin Infect Dis 1994;18:354-357
68. Haedicke TA. Cerebral Schistosomiasis. A report of 10 cases caused by Schistosomiasis japonica. Minn Med 1972;55: 1105-1114
69. Pittella JE. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis. A review. J Trop Med Hyg 1991; 94:15-21
70. Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain 1985;108:1023-1038
71. File S. Interaction of schistosome eggs with vascular endothelium. J Parasitol 1995;81:234-238
72. Stuiver PC. Acute schistosomiasis (Katayama fever). Br Med J (Clin Res Ed) 1984;288:221-222
73. King CH, Mahmoud AA. Drugs five years later: praziquantel. Ann Intern Med 1989;110:290-296
74. Jukes MC, Nokes CA, Alcock KJ, et al. Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health 2002;7:104-117
75. Brinkmann UK, Powollik W, Werler C, Traore M. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field. Trop Med Parasitol 1988;39:162-166
76. Ferrari TC, Moreira PR, Oliveira RC, et al. The value of an enzyme-linked immunosorbent assay for the diagnosis of schistosomiasis mansoni myeloradiculopathy. Trans R Soc Trop Med Hyg 1995;89:496-500
77. Gjerde IO, Mork S, Larsen JL, et al. Cerebral schistosomiasis presenting as a brain tumor. Eur Neurol 1984;23:229-236
78. Fowler R, Lee C, Keystone JS. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg 1999;61:47-50
79. Ching HT, Clark AE, Hendrix VJ, et al. MR imaging appearance of intracerebral schistosomiasis. AJR Am J Roentgenol 1994;162:693-694
80. Preidler KW, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol 1996;17:1598-1600
81. Kardaman MW, Amin MA, Fenwick A, et al. A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan. Ann Trop Med Parasitol 1983;77:297-304
82. Watt G, Adapon B, Long GW, et al. Praziquantel in treatment of cerebral schistosomiasis. Lancet 1986;2:529-532
83. Ferrari ML, Coelho PM, Antunes CM, et al. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ 2003;81:190-196
84. Xiao S, Tanner M, N'Goran EK, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 2002;82:175-181
85. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003;98:577-591
86. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-962
87. Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002;97:603-612
88. Leiby DA, Herron RM Jr, Read EJ, et al. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002;42:549-555
89. Sanchez-Guillen MC, Barnabe C, Guegan JF, et al. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz 2002;97:947-952
90. Leiguarda R, Roncoroni A, Tararuto AT, et al. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology 1990;40:850-851
91. Kirk ML, Schofield CJ. Density-dependent timing of defaecation by Rhodnius prolixus, and its implications for the transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1987;81:348-349
92. Hall BF, Joiner KA. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences. J Eukaryot Microbiol 1993;40:207-213
93. Anez N, Carrasco H, Parada H, et al. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg 1999;60:215-222
94. Delaporte F. Romana's sign. J Hist Biol 1997;30:357-366
95. Dias JC. [Cecilio Romana, Romana's sign and Chagas' disease]. Rev Soc Bras Med Trop 1997;30:407-413
96. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001;1:92-100
97. Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997;60:187-193
98. Matsumoto TK, Hoshino-Shimizu S, Nakamura PM, et al. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. J Clin Microbiol 1993;31:1486-1492
99. Umezawa ES, Nascimento MS, Stolf AM. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease. Diagn Microbiol Infect Dis 2001;39:169-176
100. Di Lorenzo GA, Pagano MA, Taratuto AL, et al. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings. J Neuroimaging 1996;6:94-97
101. Urbina JA. Specific treatment of Chagas disease: current status and new developments. Curr Opin Infect Dis 2001;14: 733-741
102. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3-24
103. Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 1994;127:151-162
104. Cerisola JA, Neves da Silva N, Prata A, et al. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)]. Bol Chil Parasitol 1977;32:51-62
105. Smith DH, Pepin J, Stich AH. Human African trypanosomiasis: an emerging public health crisis. Br Med Bull 1998; 54:341-355
106. Van Nieuwenhove S, Beru-Ku-Mesu VK, Diabakana PM, et al. Sleeping sickness resurgence in the DRC: the past decade. Trop Med Int Health 2001;6:335-341
107. Welburn SC, Fevre EM, Coleman PG, et al. Sleeping sickness: a tale of two diseases. Trends Parasitol 2001;17: 19-24
108. McGovern TW, Williams W, Fitzpatrick JE, et al. Cutaneous manifestations of African trypanosomiasis. Arch Dermatol 1995;131:1178-1182
109. Kristensson K, Mhlanga JD, Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Curr Top Microbiol Immunol 2002;265:227-257
110. Villanueva MS. Trypanosomiasis of the central nervous system. Semin Neurol 1993;13:209-218
111. Enanga B, Burchmore RJ, Stewart ML, Barrett MP. Sleeping sickness and the brain. Cell Mol Life Sci 2002; 59:845-858
112. Mhlanga JD, Bentivoglio M, Kristensson K. Neurobiology of cerebral malaria and African sleeping sickness. Brain Res Bull 1997;44:579-589
113. Lejon V, Buscher P. Stage determination and follow-up in sleeping sickness. Med Trop (Mars) 2001;61:355-360
114. Gill DS, Chatha DS, del Carpio-O'Donovan R. MR imaging findings in African trypansomiasis. AJNR Am J Neuroradiol 2003;24:1383-1385
115. Nok AJ. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res 2003;90:71-79
116. Matovu E, Enyaru JC, Legros D, et al. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health 2001;6:407-411
117. Docampo R, Moreno SN. Current chemotherapy of human African trypanosomiasis. Parasitol Res 2003;90(suppl 1): S10-S13
118. Parija SC, Jayakeerthee SR. Naegleria fowleri: a free living amoeba of emerging medical importance. J Commun Dis 1999;31:153-159
119. Gyori E. December 2002: 19-year old male with febrile illness after jet ski accident. Brain Pathol 2003;13:237-239
120. Jain R, Prabhakar S, Modi M, et al. Naegleria meningitis: a rare survival. Neurol India 2002;50:470-472
121. Barnett ND, Kaplan AM, Hopkin RJ, et al. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol 1996;15:230-234
122. Martinez AJ. Free-living amebic meningoencephalitides: comparative study. Neurol Neurocir Psiquiatr 1977;18:391-401
123. Carter RF. Primary amoebic meningo-encephalitis: clinical, pathological and epidemiological features of six fatal cases. J Pathol Bacteriol 1968;96:1-25
124. Viriyavejakul P, Rochanawutanon M, Sirinavin S. Naegleria meningomyeloencephalitis. Southeast Asian J Trop Med Public Health 1997;28:237-240
125. Reveiller FL, Cabanes PA, Marciano-Cabral F. Development of a nested PCR assay to detect the pathogenic free-living amoeba Naegleria fowleri. Parasitol Res 2002;88:443-450
126. Schumacher DJ, Tien RD, Lane K. Neuroimaging findings in rare amebic infections of the central nervous system. AJNR Am J Neuroradiol 1995;16:930-935
127. Ferrante A. Free-living amoebae: pathogenicity and immunity. Parasite Immunol 1991;13:31-47
128. Loschiavo F, Ventura-Spagnolo T, Sessa E, Bramanti P. Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome. Acta Neurol (Napoli) 1993;15:333-340
129. Seidel JS, Harmatz P, Visvesvara GS, et al. Successful treatment of primary amebic meningoencephalitis. N Engl J Med 1982;306:346-348
130. Sell JJ, Rupp FW, Orrison WW Jr. Granulomatous amebic encephalitis caused by acanthamoeba. Neuroradiology 1997; 39:434-436
131. Deol I, Robledo L, Meza A, et al. Encephalitis due to a free-living amoeba (Balamuthia mandrillaris): case report with literature review. Surg Neurol 2000;53:611-616
132. Healy JF. Balamuthia amebic encephalitis: radiographic and pathologic findings. AJNR Am J Neuroradiol 2002;23:486-489
133. McCulley JP, Alizadeh H, Niederkorn JY. The diagnosis and management of Acanthamoeba keratitis. CLAO J 2000; 26:47-51
134. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003;16:273-307
135. Denney CF, Iragui VJ, Uber-Zak LD, et al. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis 1997;25:1354-1358
136. Martinez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol 1997;7:583-598
137. Singhal T, Bajpai A, Kalra V, et al. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J 2001;20:623-627